Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MYL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CASC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FAM198A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNA11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR490 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929964 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HAPLN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOCS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF826P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929340 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR2L1P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZSCAN10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRDX6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ICE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TYR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on